Resolution of Fatty Liver and Risk of Incident Diabetes
Overview
Affiliations
Context: Fatty liver is associated with an increased risk of type 2 diabetes, but whether an increased risk remains in people in whom fatty liver resolves over time is not known.
Objective: The objective of the study was to assess the risk of incident diabetes at a 5-year follow-up in people in whom: 1) new fatty liver developed; 2) existing fatty liver resolved, and 3) fatty liver severity worsened over 5 years.
Design And Methods: A total of 13,218 people without diabetes at baseline from a Korean occupational cohort were examined at baseline and after 5 years, using a retrospective study design. Fatty liver status was assessed at baseline and follow-up as absent, mild, or moderate/severe using standard ultrasound criteria. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for incident diabetes at follow-up were estimated after controlling for multiple potential confounders.
Results: Two hundred thirty-four people developed incident diabetes. Over 5 years, fatty liver resolved in 828, developed in 1640, and progressed from mild to moderate/severe in 324 people. Resolution of fatty liver was not associated with a risk of incident diabetes [aOR 0.95 (95% CIs 0.46, 1.96), P = .89]. Development of new fatty liver was associated with incident diabetes [aOR 2.49 (95% CI 1.49, 4.14), P < .001]. In individuals in whom severity of fatty liver worsened over 5 years (from mild to moderate/severe), there was a marked increase in the risk of incident diabetes [aOR 6.13 (2.56, 95% CI 14.68) P < .001 (compared with the risk in people with resolution of fatty liver)].
Conclusion: Change in fatty liver status over time is associated with markedly variable risks of incident diabetes.
Zeng H, Yu F, Hu H, Han Y, Ye R, Cao C Sci Rep. 2025; 15(1):4269.
PMID: 39905126 PMC: 11794635. DOI: 10.1038/s41598-025-88314-8.
Gu X, Gao D, Zhou X, Ding Y, Shi W, Park J Front Cardiovasc Med. 2024; 11:1433807.
PMID: 39301498 PMC: 11411361. DOI: 10.3389/fcvm.2024.1433807.
Sharafi M, Mohsenpour M, Afrashteh S, Eftekhari M, Dehghan A, Farhadi A BMC Med Inform Decis Mak. 2024; 24(1):246.
PMID: 39227824 PMC: 11373449. DOI: 10.1186/s12911-024-02648-3.
The role of ferroptosis in DM-induced liver injury.
Wu K, Chen J, Lin J, Zhu E, Xu X, Yan X Biometals. 2024; 37(5):1191-1200.
PMID: 38874821 DOI: 10.1007/s10534-024-00600-6.
El-Shreef H, Taha O, Ahmed Abd El Hafeez H, Shoka A Diabetol Metab Syndr. 2024; 16(1):47.
PMID: 38369509 PMC: 10875815. DOI: 10.1186/s13098-024-01281-4.